1. Andersson B, Beran M (1980) Leukemic cell versus plasma levels of daunorubicin and daunorubicinol after infusion of daunorubicin as free drug or the DNA complex. Cancer Chemother Pharmacol 4:205
2. Baurain R, Deprez-De Campeneere D, Zenebergh A, Trouet A (1982) Plasma levels of doxorubicin after IV bolus injection and infusion of the doxorubicin ? DNA complex in rabbits and man. Cancer Chemother Pharmacol 9:93
3. Benjamin RS, Riggs CE, Bachur NR (1977) Plasma pharmacokinetics of adriamycin and its metabolites in humans with normal hepatic and renal function. Cancer Res 37:1416
4. Benjamin RS, Mason JW, Billingham ME (1978) Cardiac toxicity of adriamycin-DNA complex and rubidazone: Evaluation by electrocardiogram and endomyocardial biopsy. Cancer Treat Rep 62:935
5. Chan KK, Cohen JL, Gross JF, Himmelstein KJ, Bateman JR, Tsu-Lee Y, Marlis AS (1978) Prediction of adriamycin disposition in cancer patients using a physiologic, pharmacokinetic model. Cancer Treat Rep 62:1161